Case Study – AM Diagnostics

Helping Australia stay safe during COVID

AM Diagnostics was the first Australian company to receive approval from the Therapeutic Goods Administration to supply rapid antigen tests domestically.  The business secured contracts worth tens of millions of dollars to supply companies and State Government with RATs.  Axito worked with AMD in opening up several of those channels through our extensive network.


“The Axito growth workshop provided us with excellent strategic and executional direction. Coupled with their network of contacts, led to significant opportunities with larger national clients, and a rapid expansion of our customer base, that would otherwise have taken us a significant amount of time to cultivate.”
Ryan Birkett, Account Manager.